Adebrelimab and Chemoradiotherapy in High-risk LANPC

Abroad (travel likely)RecruitingPHASE2

Conditions

Nasopharyngeal Carcinoma · Nasopharyngeal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

    Contact: Study coordinator (Sangang Wu, M.D.) · wusg@xmu.edu.cn · 0592-2132222
  • Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Jian Guan, M.D.)
  • Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

    Contact: Study coordinator (jun ma, M.D.) · majun2@mail.sysu.edu.cn · +862087343469
  • West China Hospital, Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (Lei Liu, M.D.)
Study leads
  • Jun Ma, M.D.

    Principal Investigator

    Sun Yat-Sen University Cancer Center